Skip to content
2000
Volume 28, Issue 2
  • ISSN: 1381-6128
  • E-ISSN: 1873-4286

Abstract

Early detection and accurate monitoring are two critical factors affecting the outcome of anticancer therapy. However, both these factors are affected by the limitations of conventional approaches of diagnosis and treatment. Nanomedicine has progressively offered a scientific solution in improved delivery and better diagnosis of various cancers, thus providing a targeted treatment approach. With the advances in the field, simultaneous delivery and diagnosis are becoming a reality. The present manuscript discusses various drug delivery challenges, provides the scope for theranostic nanomaterials in the diagnosis and treatment of cancer. The clinical and translational potential of theranostic nanomedicine and the future directions for further research are also presented in the manuscript.

Loading

Article metrics loading...

/content/journals/cpd/10.2174/1381612827666210916140627
2022-01-01
2025-07-11
Loading full text...

Full text loading...

/content/journals/cpd/10.2174/1381612827666210916140627
Loading

  • Article Type:
    Review Article
Keyword(s): cancer; chemotherapy; drug delivery; nanomaterials in cancer; Nanomedicine; theranostics
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test